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Abstract
Aurora-A, a centrosomal serine-threonine kinase, orchestrates several key aspects of cell division. However, the regulatory
pathways for the protein stability and kinase activity of Aurora-A are still not completely understood. In this study, PUM2, an
RNA-binding protein, is identified as a novel substrate and interacting protein of Aurora-A. Overexpression of the PUM2
mutant which fails to interact with Aurora-A, and depletion of PUM2 result in a decrease in the amount of Aurora-A. PUM2
physically binds to the D-box of Aurora-A, which is recognized by APC/C
Cdh1. Overexpression of PUM2 prevents
ubiquitination and enhances the protein stability of Aurora-A, suggesting that PUM2 protects Aurora-A from APC/C
Cdh1-
mediated degradation. Moreover, association of PUM2 with Aurora-A not only makes Aurora-A more stable but also
enhances the kinase activity of Aurora-A. Our study suggests that PUM2 plays two different but important roles during cell
cycle progression. In interphase, PUM2 localizes in cytoplasm and plays as translational repressor through its RNA binding
domain. However, in mitosis, PUM2 physically associates with Aurora-A to ensure enough active Aurora-A at centrosomes
for mitotic entry. This is the first time to reveal the moonlight role of PUM2 in mitosis.
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Introduction
Aurora-A is a centrosomal serine-threonine kinase that regulates
many processes during cell division. Both the expression and
kinase activity of Aurora-A are tightly cell cycle-regulated, peaking
when cells enter the M phase [1]. Mechanistically, the best
understood roles of Aurora-A relate to the recruitment and
regulation of proteins at the centrosomes. Aurora-A and its
substrates complete the assignments in cell division coordinately
through phosphorylation reactions, such as centrosome matura-
tion, spindle assembly, mitotic commitment and cytokinesis [2].
Instead of serving as downstream effectors, some Aurora-A
substrates and interacting proteins such as the microtubule-
associated protein TPX2 [3,4], the LIM domain-containing
protein Ajuba [5] and the focal-adhesion protein PAK1 [6], play
roles as upstream regulators that mediate Aurora-A kinase activity.
Aurora-A activity is regulated by auto- or transphosphorylation at
a conserved threonine residue (threonine-288 in humans) [1,7].
Ajuba is involved in Aurora-A autophosphorylation, whereas
PAK1 phosphorylates Aurora-A at threonine-288. Otherwise,
upon binding to TPX2, a global conformational change of
Aurora-A is triggered and the domain that contains phosphory-
lated threonine-288 enters a phosphatase-inaccessible conforma-
tion, increasing the kinase activity of Aurora-A [4]. Upon exit from
mitosis, the Aurora-A kinase activity rapidly declines, and the
protein is recognized by E3 ubiquitin ligase, APC/C
Cdh1, and
degraded by the ubiquitin-proteosome dependent mechanism
[8,9,10,11]. However, the regulatory pathways for kinase activity
and the protein concentration of Aurora-A in cells are still not
completely understood. Most of the reported Aurora-A substrates
and interacting protein partners (which are Aurora-A regulators)
act as kinase-activating factors when the cells enter the M phase,
yet none have been identified as a factor that enhances the protein
stability of Aurora-A. Besides, the expression of Aurora-A at the
transcriptional level only increases to a small extent at the G2/M
transition [12]. It remains to be elucidated how the protein quan-
tity of Aurora-A can peak so dramatically, causing mitotic entry.
PUM2 (Human Pumilio homology protein 2), which is a
member of the PUF protein family, has been reported to bind to 39
untranslated regions (39 UTRs) of mRNA and to repress gene
expression by controlling cytoplasmic polyadenylation and affect-
ing mRNA translation [13,14,15]. Interestingly, several studies on
the maturation of Xenopus oocytes reveal that Aurora-A is also
involved in this regulation and that PUM2 contributes to a
selective translational repression of maternal cyclin B1 mRNA
[16,17]. When translationally dormant, PUM2, CPEB (CPE-
binding protein) and Maskin form a complex on maternal cyclin
B1 mRNA, precluding the formation of the active translation
initiation complex. Aurora-A then promotes poly(A) elongation by
phosphorylating CPEB, causing dissociation of the PUM2-CPEB-
Maskin-eIF4E complex [18,19,20,21]. Surprisingly, Maskin has
been identified as the homologue of TACC3, a well-characterized
substrate of Aurora-A [22]. TACC3 is required for microtubule
assembly during the M-phase and is localized at the centrosomes,
as regulated by Aurora-A [23]. Moreover, CPEB is present on the
mitotic apparatus [24]. Two components of the protein complex
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19718that are involved in regulating the translation of Xenopus maternal
cyclin B1 mRNA are substrates of Aurora-A and both of these also
have roles in cell division. This raises the possibility that PUM2
might also have a second role in controlling the progression of cell
cycle like Maskin and CPEB.
Here we demonstrate that PUM2 is a novel substrate of andbinds to
Aurora-A. Binding to PUM2 protects Aurora-A from the protein
ubiquitination/degradation mediated by APC/C
Cdh1,a n dt h a ti s
required for the dramatic increase in the kinase activity of Aurora-A,
causing mitotic entry. This study reveals that PUM2 plays an ad-
ditional role in mitotic control, apart from its role in translational
regulation during interphase. This finding supports the notion that cells
e m p l o yt h es a m ec o m p o n e n t su s e di ni n t e r p h a s et or e g u l a t em i t o s i s .
Results
PUM2 is a substrate of Aurora-A kinase and its expression
is cell cycle-regulated
To test the hypothesis that PUM2 may have roles in the
regulation of the progression of cell cycle, and that it is functionally
linked to the mitotic kinase Aurora-A, we first determined whether
the protein expression and intracellular localization of PUM2 was
cell cycle-regulated. As compared to asynchronous cells, high
levels of Aurora-A were detected in nocodazole-arrested mitotic
cells, in line with previous observations [1] (Figure 1A). In
addition, high levels of PUM2 were observed in these cells.
Interestingly, PUM2 also exhibited an electrophoretic mobility up-
shift, possibly caused by phosphorylation (Figure 1A). After release
from nocodazole arrest, the protein level of PUM2 went down and
its electrophoretic mobility up-shift disappeared in parallel to the
concentration of Aurora-A in cells (Figure 1A). Moreover, PUM2
and Aurora-A colocalized to the centrosomes from S phase to
metaphase (Figure 1B). These data suggest that PUM2 is
functionally linked to Aurora-A.
To determine whether Aurora-A can phosphorylate PUM2 and
hence lead to its electrophoretic mobility up-shift, FLAG-tagged
PUM2 and wild-type Aurora-A or kinase-dead Aurora-A-K162I
were cotransfected into HEK293T cells for analysis. In the presence
of wild-type Aurora-A, PUM2 exhibited an apparent electropho-
retic mobility up-shift, and the up-shift could be abolished by l
protein phosphatase. In contrast, in the presence of Aurora-A-
K162I, PUM2 did not show the electrophoretic mobility up-shift
(Figure 1C).Theelectrophoreticmobilityup-shiftofPUM2 wasalso
examined by performing immunoprecipitation using anti-FLAG
antibody to precipitate FLAG-tagged PUM2 from cell lysates
followed by l protein phosphatase treatment with or without
protein phosphatase inhibitor, and similar phenomenon was
observed (Figure S1). Moreover, in Aurora-A-depleted cells, the
M phase-specific electrophoretic mobility shift of PUM2 was
abolished (Figure 1D). These results suggest that PUM2 is a mitotic
phosphoprotein and its phosphorylation is dependent upon Aurora-
A. To confirm this, we performed in vitro kinase assay. Recombinant
GST-tagged PUM2 or FLAG-tagged PUM2 immunoprecipitated
from cell lysates was incubated either alone or in combination with
His-tagged Aurora-A in a kinase buffer containing [c-
32P]-ATP.
Phospho-PUM2 radioactivity was detected only in the presence of
Aurora-A (Figure 1E, Figure 1F and Figure S2). Taken together, we
conclude that PUM2 is a novel substrate of Aurora-A.
The novel role of PUM2 in cells apart from the well-known
role in the regulation of translation: to stabilize Aurora-A
through physical interaction
Given the colocalization of PUM2 with Aurora-A, we
determined whether PUM2 and Aurora-A were present in the
same complex. Therefore, HEK293T cells were transfected with
HA-tagged Aurora-A, either alone or in combination with FLAG-
tagged PUM2. By performing co-immunoprecipitation using anti-
FLAG antibody and immunoblot analysis using the anti-HA
antibody, Aurora-A was co-precipitated with PUM2 from cell
lysates, suggesting that PUM2 interacts with Aurora-A either
directly or via intermediate proteins (Figure 2A). To determine
whether PUM2 directly interacted with Aurora-A, we performed
an in vitro GST pull down assay. Bacterially-expressed, purified
GST-PUM2 fusion protein or GST protein on glutathione-
Sepharose 4B beads was incubated with purified His-tagged wild-
type Aurora-A or kinase-inactive mutant protein (Aurora-A-
K162I). We found that GST-PUM2 could bind to His-tagged
Aurora-A, whereas GST could not (Figure 2B), indicating that
PUM2 directly binds to Aurora A. In addition, it is worthy to note
that the kinase activity of Aurora-A defective mutant (Aurora-A-
K162I) showed low binding affinity with PUM2 comparing with
the wild-type Aurora-A. This suggests that the binding of these two
proteins is positively related to the kinase activity of Aurora-A.
PUM2 might first be phosphorylated by Aurora-A and this
phosphorylation promotes the binding between these two proteins.
It was in further detail to investigate if endogenous PUM2 could
interact with Aurora-A by the application of the in situ proximity
ligation assay (PLA), that enables the detection and quantification
of protein–protein interactions in native cells [25]. Complexes
between endogenous PUM2 and Aurora-A were visualized by
staining CL1–5 cells with anti-PUM2 and anti-Aurora-A antibod-
ies, where individual primary antibody was performed as negative
controls. The distance between the two primary antibodies needs
to be less than 40 nm for the PLA assay to generate a red dot
signal, which represents an interaction. Results shown in Figure 2C
clearly indicates the presence of PUM2/Aurora-A complexs
signals, revealing endogenous PUM2 could interact with Aurora-
A.
Three putative domains including the S motif (serine rich
regions), the Q/A motif (glutamine/alanine-rich regions) and the
PUM-HD motif (RNA-binding domain), are present in PUM2
[13]. Five PUM2 truncation mutants were thus generated based
on these motifs (left panel of Figure 2D). By performing co-
immunoprecipitation assay, we examined the abilities of these
PUM2 truncation mutant proteins to associate with Aurora-A.
The results showed that the N-terminal fragment (aa 1–742 and aa
1–646) that contained the complete Q/A and S motifs had the
strongest affinity for Aurora-A. The N-terminal fragment (aa 1–
433), which included the Q/A motif but not the S motif, had a
very low affinity for Aurora-A. However, various fragments
containing different truncated C-terminal derivatives (aa 741–
1064 and aa 645–1064) also had weak affinities for Aurora-A
(Figure 2D). This revealed the S motif of PUM2 is required for the
interaction with Aurora-A. To further verify the Aurora-A-binding
region in PUM2, we generated three deleted PUM2 mutants,
PUM2D277–434, lacking the Q/A motif, PUM2D434–644,
lacking the S motif and PUM2D434–740, lacking the S motif
and the sequence preceding the PUM-HD motif. PUM2D277–
434 and PUM2D434–644 were able to bind to Aurora-A, but
PUM2D434–740 was not (Figure 2D and Figure S3), supporting
the idea that the S motif of PUM2 is responsible for binding to
Aurora-A. Moreover, the sequence preceding the PUM-HD motif
of PUM2 is also important for this interaction. In previous study,
the PUM-HD motif of PUM2 is responsible for the well-known
role as translational repressor [14]. However, our results showed
that the N-terminal fragment (aa 1–742) which lacked the PUM-
HD motif still could bind to Aurora-A and another motif, the S
motif, is responsible for this interaction. This revealed that PUM2
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PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e19718Figure 1. The cell cycle-regulated protein, PUM2, is a novel substrate of Aurora-A kinase. (A) PUM2 exhibites remarkably variations both
in protein quantity and phosphorylation state during exit from the G2/M block. HeLa cells were synchronized in the G2/M phase by treatment with
nocodazole for 16 hrs and subsequently released into cell cycle progression by removal of the nocodazole. At the indicated time points, the cells
were harvested and analyzed by immunoblotting. Asynchronously (Asy) growing cells were analyzed in parallel. (B) PUM2 was localized at the
centrosomes from S phase to metaphase. The CL1–5 cells were fixed and probed with anti-PUM2 antibody (green) and anti-Aurora-A antibody (red),
and the DNA was stained with DAPI (blue). The cells were visualized using confocal fluorescence microscopy. (C) PUM2 is a novel substrate for Aurora-
A. HEK293T cells were transfected with FLAG-tagged PUM2 in combination with FLAG-tagged Aurora-A (the wild-type or kinase-inactive mutant). To
confirm whether the gel mobility up-shift was derived from phosphorylated PUM2, the cell lysates were treated with and without l protein
phosphatase. (D) The M phase-specific electrophoretic mobility shift of PUM2 is abolished in Aurora-A-depleted cells. HeLa cells were transfected with
Aurora-A specific siRNA (siAur-A) and synchronized in the G2/M phase by treatment with nocodazole for 16 hrs. The cells were harvested and
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in the regulation of translation.
Of particular interest is that the amount of ectopically expressed
Aurora-A proteins was higher in cells transfected with Aurora-A
alone than in cells co-expressed with PUM2 and Aurora-A (left
panel of Figure 2A). It raises the possibility that PUM2 might
stabilize Aurora-A protein and hence result in an accumulation of
Aurora-A. To test this possibility, we investigated whether
increasing amounts of PUM2 correlate with increased steady-state
protein level of Aurora-A. We co-expressed Aurora-A (1 mg) with
different amounts of PUM2, and immunoblotting analysis
revealed that the increase in the protein amount of Aurora-A
was accompanied by a substantial dose dependent increase in the
steady-state protein amount of PUM2 (Figure 3A). Consistent with
this hypothesis, the depletion of endogenous PUM2 by siRNA also
resulted in a decrease in the steady state level of Aurora-A (left
panel of Figure 3B). To further examine the specificity of PUM2
siRNA, the rescue assay with siRNA-resistant FLAG-PUM2
(siRNA-R-FLAG-PUM2) was performed. Three nucleotides of
wild-type PUM2 were mutated to create resistance to PUM2
siRNA, and the encoding protein was not altered. It was shown the
effect of PUM2 siRNA in the steady state level of Aurora-A is
restored by re-expressing the RNAi-resistant FLAG-PUM2 (right
panel of Figure 3B).
To determine whether PUM2 stabilize Aurora-A at protein
level, we examined the effect of PUM2 on the protein turnover
rate of endogenous Aurora-A. The cycloheximide (CHX) chase
experiment was performed using cell lysates from nocodazole-
arrested M-phase cells and late anaphase/early G1-phase cells that
were released from nocodazole block. It was shown that Aurora-A
was stabilized in M-phase cells overexpressing PUM2 and had a
half-life of longer than 3 hours but it had a half-life of less than
3 hours in cells transfected with empty vector (middle panel of
Figure 3C). Similarly, after release from nocodazole arrest,
Aurora-A was highly stabilized in cells overexpressing PUM2,
with a half-life of longer than 6 hours as compared to a half-life of
less than 1 hour in cells transfected with the empty vector (right
panel of Figure 3C). These results indicate that Aurora-A is rapidly
degraded during mitotic exit and this degradation can be
prevented by overexpression of PUM2.
To explore how PUM2 stabilizes Aurora-A, we determined
whether the interactions between Aurora-A and PUM2 are
necessary for modulating the protein stability of Aurora-A. If
these two events are correlated, Aurora-A binding-deficient
mutant(s) of PUM2 should lose the ability to stabilize Aurora-A.
As compared to cells transfected with wild-type PUM2 or the
PUM2 mutant proteins which could not interact with Aurora-A,
PUM2D434–740, the protein level of Aurora-A was much lower in
cells transfected with this PUM2 deleted mutant protein
(Figure 3D). These indicated that binding of PUM2 to Aurora-A
is required to stabilize Aurora-A. Taken together, these results led
to the conclusion that PUM2 is required to maintain sufficient
amounts of Aurora-A in the cells, which is indispensable for the
interaction between Aurora-A and PUM2.
Binding of PUM2 to Aurora-A protects Aurora-A from
APC/C
Cdh1-mediated degradation
It is known that the ubiquitin ligase APC/C
Cdh1 targets the
amino-terminal A-box and carboxy-terminal D-box sequences of
Aurora-A for proteolysis. Consistent with previous observation
[10], when Aurora-A was co-expressed with different amounts of
Cdh1 in HEK293T cells, the increase in the protein level of Cdh1
was accompanied by a substantial decrease in the expression levels
of Aurora-A. However, overexpression of Cdc20 did not affect the
expression level of Aurora-A (Figure S4).
Since the association between Aurora-A and PUM2 is necessary
for enhancing the stability of Aurora-A, PUM2 should first
physically interact with Aurora-A and then modulate its protein
stability. We reasoned that PUM2 should prevent Aurora-A from
APC/C
Cdh1-dependent ubiquitination directly. It was expected
that Aurora-A might be less susceptible to ubiquitination in cells
when PUM2 is overexpressed. Different amounts of FLAG-tagged
PUM2 were co-expressed with FLAG-tagged Aurora-A and Myc-
tagged ubiquitin in HEK293T cells. 24 hrs after transfection, cells
were treated with the proteasome inhibitor MG132 to allow
accumulation of ubiquitinated forms of Aurora-A at the timepoint
when G2/M-arrested cells were released into the cell cycle
progression. As expected, Aurora-A was less susceptible to
ubiquitination in cells in which PUM2 was overexpressed
(Figure 4A). Increasing the protein level and protein stability of
Aurora-A were correlated with increased PUM2 expression. This
observation suggests that PUM2 can physically interact with
Aurora-A, thereby preventing it from being targeted by APC/
C
Cdh1 for ubiquitination.
We speculated that PUM2 might bind to the amino-terminal A-
box or the carboxy-terminal D-box of Aurora-A to prevent the
recognition by APC/C
Cdh1. To test this speculation, the PUM2-
binding domain of Aurora-A was mapped by co-immunoprecip-
itation assay using anti-HA antibody. Flag-PUM2 was cotrans-
fected with various HA-Aurora-A truncation mutants into cells for
co-immunoprecipitation assay. Figure 4B shows that the Aurora-
A(1–131) and Aurora-A(1–362) failed to associate with PUM2,
and that the carboxy-terminal D-box of Aurora-A seemed to be as
an essential determinant for the interaction between Aurora-A and
PUM2. This suggests that PUM2 may protect Aurora-A from
attack by APC/C
Cdh1 on the D-box and thereby enhance its
stability.
Increase of Aurora-A kinase activity by PUM2 in vitro
Our observations that PUM2 could stabilize Aurora-A
suggest that PUM2 might serve as an upstream regulator of
Aurora-A. In general, there are two routes by which protein
kinases are regulated: one, through modulating its quantity in
cells and two, through modulating the kinase activity. To
determine the effect of PUM2 on activating Aurora-A, an in vitro
kinase assay was performed to measure the activity of Aurora-A
by using Histone-H3 as a substrate. Different amounts of
purified GST-PUM2 recombinant proteins were incubated with
His-tagged Aurora-A in kinase reaction buffer containing ATP.
It was found that the phosphorylation of Histone-H3 was
markedly increased by the addition of PUM2 in a dose-
dependent manner (Figure 5). Although we could not exclude
the possibility that PUM2 is also a downstream effector of
Aurora-A during cell division, these results strongly argue that
PUM2 is an upstream regulator of Aurora-A and that it not only
serves as an Aurora-A stabilization factor but also serves as an
Aurora-A-activating factor.
analyzed by immunoblotting. (E, F) PUM2 is an in vitro substrate of Aurora-A. GST-tagged PUM2 (E) or FLAG-tagged PUM2 immunoprecipitated from
cell lysates (F) was incubated, either alone or in combination with recombinant His-tagged Aurora-A, in the presence of [c-32P]-ATP. The samples
were electrophoresed using SDS-PAGE and transferred to a PVDF membrane. They were then either autoradiographed or immunoblotted.
doi:10.1371/journal.pone.0019718.g001
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Here we report two main findings. First, the translational
regulator, PUM2, is a cell cycle-regulated protein and a novel
substrate of Aurora-A. Second, PUM2 can interact with Aurora-
A to protect Aurora-A from APC/C
Cdh1-mediated protein
ubiquitination/degradation and to enhance the kinase activity
of Aurora-A. This reveals the moonlight role of PUM2 in mitotic
control, apart from its role in translational regulation during
interphase.
Befitting that Aurora-A kinase plays a central role in cell
division, the substrates of this kinase include various cell cycle
regulatory proteins such as TPX2 [26], TACC3 [23], HURP
[27,28], Eg5 [29], CDC25B [30], Ajuba [5] and PAK1 [6].
Figure 2. PUM2 interacts physically with Aurora-A, and the S motifs, not the PUM-HD motif, of PUM2 are required for this
interaction. (A) PUM2 forms a complex with Aurora-A in HEK293T cells. HEK293T cells were transfected with HA-tagged Aurora-A, either alone or in
combination with FLAG-tagged PUM2. The samples were immunoprecipitated using an anti-FLAG antibody and then immunoblotted with an anti-
HA antibody to detect Aurora-A. (B) Recombinant Aurora-A and PUM2 form a complex as determined using a GST pull down assay. Purified GST-
PUM2 fusion protein or a control (GST immobilized on glutathione-Sepharose 4B beads) was incubated with purified His-tagged Aurora-A or kinase-
inactive mutant protein (Aurora-A-K162I). Bead-bound proteins were immunoblotted against an anti-His antibody, and the gel was also stained with
coomassie blue. His-tagged Aurora-A and kinase-inactive mutant protein alone are also shown. (C) Detection of endogenous PUM2-Aurora-A
complexes by in situ proximity ligation assay (PLA). Complexes between endogenous PUM2 and Aurora-A were visualized by staining CL1–5 cells with
anti-PUM2 and anti-Aurora-A antibodies. Each red dot represented an interaction detected by the PLA assay. DNA was stained with DAPI (blue) and
the cells were visualized using confocal fluorescence microscopy. (D) The S motifs of PUM2 are required for the interaction with Aurora-A. Five PUM2
truncation mutants and three deleted PUM2 mutants were generated based on the putative domains present in PUM2. HEK293T cells were
transfected with HA-tagged Aurora-A and various FLAG-tagged PUM2 mutants. The cell lysates were immunoprecipitated with an anti-FLAG antibody
and then immunoblotted with an anti-HA antibody to detect Aurora-A.
doi:10.1371/journal.pone.0019718.g002
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least some of the cell cycle activities that have been ascribed to
Aurora-A. It is imperative to identify any additional substrates and
interacting proteins that may exist to complete the description of
the role of Aurora-A in the regulation of mitosis. PUM2, a novel
Aurora-A substrate that has been identified in this study, has a
well-known role in the regulation of translation. Interestingly, our
results suggest an additional novel role of PUM2 in serving as an
upstream regulator of Aurora-A through physical interaction. The
molecular mechanism of PUM2-mediated kinase regulation acts to
both activate and stabilize Aurora-A. PUM2 could affect the cell
cycle progression through regulation of Aurora-A.
Overexpression of the PUM2 mutant, which failed to interact
with Aurora-A, and depletion of PUM2 both led to the
destabilization of Aurora-A (Figure 3). This was made evident
by the low susceptibility of Aurora-A to ubiquitination in cells in
which PUM2 was overexpressed (Figure 4A). Moreover, the
carboxy-terminal D-box of Aurora-A was shown to be the region
Figure 3. PUM2 is able to enhance the protein stability of Aurora-A, which is indispensable for the interaction between Aurora-A
and PUM2. (A) The stability of Aurora-A is regulated by PUM2. HEK293T cells were transfected with FLAG-tagged Aurora-A, either alone or with
different amounts of FLAG-tagged PUM2. The cell lysates were analyzed by immunoblotting. (B) Knock-down of PUM2 results in the down-regulation
of both PUM2 and Aurora-A. HEK293T cells were transfected with PUM2 specific siRNA or in combination with siRNA-R-FLAG-PUM2 and the effect of
steady-state protein level of Aurora-A was determined using immunoblotting analysis. The relative intensity of protein bands on immunoblotting
were quantified and normalized to GAPDH. (C) PUM2 protects Aurora-A from protein degradation when the cells exit from mitosis. HEK293T cells
were transiently transfected with an empty vector or with FLAG-tagged PUM2. 24 hrs after transfection, the cells were synchronized in mitosis by
nocodazole. For the collection of cells exiting from M phase, the cells were released into the cell cycle progression by removing the mitosis-
synchronizing reagent and subsequently incubated with fresh medium containing cycloheximide, which blocks de novo protein synthesis. For the
collection of M phase cells, the cells were also treated with nocodazole but this mitosis-synchronizing reagent was not removed when incubating
with cycloheximide-containing medium. At the indicated time points, the cells were harvested and the lysates were immunoblotted with anti-PUM2,
anti-FLAG, anti-Aurora-A and anti-GAPDH antibodies. Asynchronously (Asy) growing cells were analyzed in parallel. (D) Overexpression of PUM2
mutant, which failed to interact with Aurora-A, leads to the destabilization of this kinase.
doi:10.1371/journal.pone.0019718.g003
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binding of PUM2 might protect Aurora-A from being attack by
APC/C
Cdh1 (Figure 6). In a recent report, the mRNAs associated
with PUM2 were systematically identified by the recovery of
endogenously formed ribonucleoprotein complexes and the
analysis of associated RNAs with DNA microarrays [31]. This
study indicated that Aurora-A mRNA was not included in the
transcripts that were reproducibly associated with PUM2. This
precluded possible effects of PUM2 on Aurora-A mRNA
translation. Moreover, it has been reported that APC/C
Cdh1 is
Figure 4. Binding of PUM2 to Aurora-A protects Aurora-A from APC/C
Cdh1-mediated degradation. (A) PUM2 blocks the ubiquitination of
Aurora-A. HEK293T cells were transfected with FLAG-tagged Aurora-A, together with different amounts of FLAG-tagged PUM2. Myc-tagged ubiquitin
was also added to reveal the ubiquitination of Aurora-A. 24 hrs after transfection, the cells were synchronized in the G2/M phase by treatment with
nocodazole for 16 hrs. Subsequently, the synchronized cells were released into cell cycle progression in the presence of a proteasome inhibitor
(MG132) for 9 hrs. High molecular weight ubiquitinated Aurora-A accumulated in the transfected cells that were treated with MG132, as shown. The
relative intensity of protein bands represented the steady-state protein level of Aurora-A on immunoblotting analysis were quantified and normalized
to GAPDH. (B) The D-box of Aurora-A mediates its association with PUM2. HEK293T cells were transfected with FLAG-tagged PUM2 and various HA-
tagged Aurora-A fragments. The cell lysates were immunoprecipitated with an anti-HA antibody and immunoblotted with an anti-FLAG antibody to
detect PUM2.
doi:10.1371/journal.pone.0019718.g004
Figure 5. Increase of Aurora-A kinase activity by PUM2 in a dose-dependent manner. Recombinant His-tagged Aurora-A or kinase-inactive
Aurora-A mutant protein (K162I) was incubated with the indicated amount of GST-PUM2 for 20 min at 30uC in kinase reaction buffer containing
histone-H3 and ATP. The activity of Aurora-A was detected by immunoblotting using the anti-phospho-Aurora-A-T288 and the anti-phospho-Histone-
H3 antibodies.
doi:10.1371/journal.pone.0019718.g005
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phosphorylation of cyclin-dependent kinase (cdk) only from late
mitosis to G1 phase [32]. Why there is PUM2 to protect Aurora-A
from being attack by APC/C
Cdh1 in early mitosis? It is reported
that timely destruction of the anaphase inhibitor, securin, by
APC/C
Cdh1 is regulated by the nucleocytoplasmic transport
factors Rae1 and Nup98 [33]. Rae1 and Nup98 would form a
complex with APC/C
Cdh1 and securin during prometaphase. This
suggested that the Rae1-Nup98 complex does not inhibit the
destruction of securin by preventing the interaction between APC/
C
Cdh1 and securin, but by preventing the ubiquitination of APC/
C
Cdh1-bound securin. It has been proposed that when securin is
restricted in the Rae1-Nup98 complex, it would prime cells for the
sudden degradation of securin at the metaphase-anaphase
transition [34]. In this study, we found that PUM2 could affect
the ubiquitination of Aurora-A by forming a complex with
Aurora-A. PUM2 might control the destruction of Aurora-A
through a similar mechanism in regulating the degradation of
securin, although it remains to be determined whether APC/
C
Cdh1 is in the PUM2-Aurora-A complex in early mitosis.
In addition to its role in enhancing protein stability, the physical
interaction of PUM2 and Aurora-A is also required for the
promotion of Aurora-A kinase activity (Figure 5). It has been
shown that PUM2 binds to the C-terminal region of Aurora-A, the
same region that has been identified as the interaction site for
TPX2 with Aurora-A [4]. This suggests that PUM2 might mediate
the kinase activity of Aurora-A through the same mechanism as
TPX2. However, only substrate phosphorylation activity of
Aurora-A was increased in the presence of PUM2, not its auto-
phosphorylation activity (Figure 5). This suggests that the
phenomenon observed might be due to another mechanism.
PUM2 is a relatively large protein containing 1064 amino acids
(theoretical molecular weight 114 kDa). Therefore, we speculated
that the proper phosphorylation and accumulation of PUM2 at
the centrosome might serve as a scaffold for the recruitment of
other Aurora-A activators such as TPX2, PAK1 and Ajuba to
regions that are proximal to the centrosomes, thereby triggering
the rapid increase in the activity of Aurora-A (Figure 6). Moreover,
it is interesting to note that PUM2 was localized in the centrosome
from S-phase to metaphase. When the cells entered anaphase,
PUM2 could not be detected in the centrosome, consistent with
the time at which Aurora-A becomes unstable and with less kinase
acitvity (Figure 1B). This indicated that PUM2 might be essential
for mitotic entry by means of the regulation of Aurora-A. Through
recruiting Aurora-A activators and protecting Aurora-A from
attack by APC/C
Cdh1, PUM2 might enhance the quantity and
activity of Aurora-A dramatically, thereby causing mitotic entry. It
will be interesting to learn if PUM2 competes or cooperates with
the other, previously identified activators or destabilization factors
of Aurora-A, and if Aurora-A interacts with more than one
regulator at a time.
It has been shown that PUM2 is involved in the regulation of
cell division as the other two factors, Maskin and CPEB, that are
involved in regulating the translation of Xenopus maternal cyclin
B1 mRNA. Besides, several studies also revealed that interphase
components might be used to regulate mitosis, and many mitotic
key regulators also have important functions during interphase.
First, RanGTP, a protein that has a well-established function in
nuclear trafficking in interphase, uses similar principles to
regulate spindle assembly in mitosis as it does during interphase
[35,36]. Another interphase component, Lamin B, which is
important for nuclear envelope assembly and in maintaining
nuclear shape, has also been reported to play a role in mitosis. It
can assemble into a matrix-like network during mitosis, and the
formation of this mitotic matrix then tethers a number of spindle
assembly factors, followed by the stimulation of microtubule
assembly [37]. Moreover, the Aurora-A activators PAK1, HEF
and Ajuba are present at focal adhesions and serve as
downstream effectors of integrin during the process of cell
migration. It is possible that disassembly of focal adhesion
molecules during mitosis releases the protein complexes and
results in the activation of Aurora-A [38].
In conclusion, all components in the PUM2-CPEB-Maskin
protein complex are not only involved in translational regulation
in interphase but also have roles in the progression of mitosis.
This finding delineates an economical design that employs




The rabbit work involved in generating antibody in this study
was done according the animal use protocol of the Institutional
Animal Care and Use Committee(IACUC)of Fu Jen Catholic
University with ethics approval number: A9856.
Figure 6. The mechanism by which PUM2 regulates the cell cycle progression. Through recruitment of the Aurora-A activator and by
protecting Aurora-A from attack by APC/C
Cdh1, PUM2 might trigger an increase in the amount of Aurora-A and increase its kinase activity
dramatically, causing mitotic entry.
doi:10.1371/journal.pone.0019718.g006
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RNA (siRNA) and Site-directed mutagenesis
Human PUM2 cDNA and Aurora-A were subcloned into
pFLAG-CMV-2 vector (Sigma) and pcDNA3.0 (Invitrogen) to
produce FLAG-tagged and HA-tagged plasmids. To generate
GST fusion protein, PUM2 cDNA were subcloned to pGEX4T-2
vector (Amersham Pharmacia Biotech). Aurora-A cDNA were
subcloned to pET29a vector (Novagen) to generate His-tagged
protein. The sequences of the siRNAs were as follows: Aurora-A
siRNA, 59-GAGUCUACCUAAUUCUGGA-39, and PUM2
siRNA, 59-GCAUGGUAGAAUAUGUAUU-39. Chemical syn-
thesized 21 nt double strand siRNAs were purchased from
Applied Biosystems. To generate siRNA-resistant form of PUM2
(siRNA-R-FLAG-PUM2), PCR-based mutagenesis (Quik-Chan-
ge
TM Site-directed mutagenesis kit, Stratagene) was used to
achieve the desired mutations.
Cell Culture, transfection, immunofluorescence analysis
and in situ proximity ligation assay (PLA)
All cell lines were purchased from the American Type Culture
Collection, and all cell culture-related reagents were purchased
from Gibco-BRL. HEK293T human embryonic kidney cells and
HeLa human cervical adenocarcinoma cells were grown in
Dulbecco’s modified Eagle’s medium containing 10% FBS,
2 mM glutamine and100 unit/ml penicillin and streptomycin
(Gibco-BRL). For maintaining CL1–5 lung cells, RPMI medium
was used. Transfection of the cells was performed with
Lipofectamine (Invitrogen) according to the manufacturer’s
instructions. For immunofluorescence analysis, cells cultured on
cover-slips for 24 hrs were fixed with 4% formaldehyde for
30 min, permeabilized with 0.5% NP-40 for 5 min, and then
stained with primary antibody at room temperature for 1 hr,
followed by addition of fluorochrome-labeled secondary antibodies
(Invitrogen) at room temperature for 50 min. For In situ proximity
ligation assay (PLA), the Rabbit PLUS and Mouse MINUS
Duolink in situ PLA kits (OLINK Bioscience) were used according
to the manufacturer’s protocol. PLA probes were diluted in 1%
fetal calf serum and incubated in a pre-heated humidity chamber
for 1 hr at 37uC, followed by hybridization, ligation, amplification
and detection. The stained slides were observed using the
Olympus FV1000 confocal fluorescence microscope.
Preparation of cell lysates, dephosphorylation assay,
immunoprecipitation and immunoblotting analysis
Cells were harvested, washed with phosphate-buffer saline
(PBS), and lysed in extraction buffer [39]. After incubation at 4uC
for 30 min, cellular debris was removed by centrifugation at
13,000 rpm for 30 min. Protein concentrations were determined
using the Bradford assay (Bio-Rad). To perform the protein
dephosphorylation experiment, lysates (50 mg) or the immunopre-
cipitation products were incubated with 400 U of l phosphatase
(New England Biolabs) in l phosphatase reaction buffer with or
without protein phosphatase inhibitor (Roche) at 30uC for 30 min.
To increase the separation of the phosphorylated and unpho-
sphorylated forms of the protein, equal amounts of treated and
untreated total lysates were loaded side by side on a SDS-PAGE,
and the acrylamide-to bisacrylamide ratio was adjusted from 29:1
to 100:1. For immunoprecipitation assay, 1 mg of total cell lysate
was incubated with antibodies against target epitopes and Protein
A/G-agarose beads (Santa Cruz) to immunoprecipitate the target
proteins. The immunoprecipitation products were resolved by
SDS-PAGE. The antibodies used in the present study were mouse
monoclonal anti-FLAG M2 (Sigma), mouse monoclonal anti-HA
(Sigma), mouse monoclonal anti-GAPDH (Santa Cruz), mouse
monoclonal anti-b actin (Sigma), mouse monoclonal anti-Aurora
A (BD), rabbit anti-phospho-Aurora-A-T288 (Cell Signaling
Technology), mouse monoclonal anti-cyclin B1 (Upstate Biotech-
nology), rabbit anti-phospho-Histone-H3 (Upstate Biotechnology).
For generating anti-PUM2 antibodies, recombinant GST-tagged
PUM2 was purified as described in method of ‘‘Preparation of
recombinant protein’’ and then injected into rabbit to raise
polyclonal PUM2 antibodies. Quantification of the intensity of
protein bands on immunoblotting analysis was performed with the
Multi Gauge software (FUJI FILM).
Preparation of recombinant protein, In vitro binding
assay and in Vitro kinase reaction
pET29a-Aurora-A and pGEX4T2-PUM2 constructs were
tramsformed in E. Coli BL21 (DE3). Recombinant His-tagged
Aurora-A and GST-tagged PUM2 were induced for 4 hr at room
temperature with 1 mM IPTG and purified from the soluble
fraction by nickel-agarose (Qiagen) and Glutathione-Sepharose
beads (Amersham Pharmacia Biotech). In in vitro binding assay,
recombinant GST-tagged PUM2 (40 mg) on Glutathione-Sephar-
ose beads was incubated with 100 mg purified recombinant His-
tagged Aurora-A in binding buffer at 4uC for overnight. After
incubation, the fusion protein-Sepharose complexes were washed
with washing buffer. The bound proteins were eluted by boiling in
the SDS sample buffer, and subjected to immunoblotting analysis.
For the in vitro kinase reaction, the purified GST-tagged PUM2
(3 mg) or FLAG-tagged PUM2 immunoprecipitated from cell
lysates was incubated with 3 mg of purified recombinant His-
tagged Aurora-A in kinase buffer [40] containing [c-
32P]-ATP.
After incubation at 30uC for 30 min, samples were subjected to
SDS-PAGE and phosphorylated PUM2 were visualized by
autoradiography.
Cell-cycle synchronization and flow cytometry analysis
To synchronize cells at the G1/S boundary or in mitosis,
exponentially cells were cultured in the presence of thymidine or
nocodazole respectively, following the protocol as previously
described [39]. Cells were released into cell cycle progression by
removing the thymidine or nocodazole followed by incubation
with fresh culture medium. At continuous time point, cells were
collected and analyzed by immunoblotting and flow cytometry
analysis. In the flow cytometry analysis, cells were fixed in 70%
ethanol and store at 4uC overnight. Cells were then washed with
PBS and treated with RNase A (0.1 mg/ml in PBS) for 5 min at
room temperature. RNase A-treated cells were stained with
propidium iodine (20 mg/ml) for at least 20 min at 4uC and
analyzed by BD FACSCanto flow cytometry system.
Cycloheximide inhibition assay
The turnover rates of proteins were determined using
cycloheximide to inhibit protein synthesis. Cells treated with
50 mg/ml cycloheximide (Sigma) were harvested at different time
point after removing the cycloheximide inhibition. Equal amounts
of cell lysates were subjected to SDS-PAGE and analyzed by
immunoblotting.
Ubiquitination assay
HEK293T cells were transfected with FLAG-tagged Aurora-A
alone or together with FLAG-tagged PUM2. Myc-tagged
ubiquitin was also added to reveal Aurora-A ubiquitination.
24 hrs after transfection, cells were synchronized in the G2/M
phase by nocodazole treatment for 16 hr. Subsequently, synchro-
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or absence of 25 mM proteasome inhibitor (MG132) for 9 hr [41].
Cells were harvested and analyzed by immunoblotting.
Supporting Information
Figure S1 Aurora-A can phosphorylate PUM2, leading
to the electrophoretic mobility up-shift of PUM2.
HEK293T cells were transfected with FLAG-tagged PUM2 in
combination with FLAG-tagged Aurora-A. The samples were
immunoprecipitated using an anti-FLAG antibody to precipitate
FLAG-tagged PUM2 from cell lysates followed by l protein
phosphatase treatment. A reaction with a protein phosphatase
inhibitor was analyzed in parallel.
(TIF)
Figure S2 Using in vitro kinase assay to confirm that
PUM2 is the substrate of Aurora-A. Different amounts of
GST-tagged PUM2 was incubated, either alone or in combination
with recombinant His-tagged Aurora-A, in the presence of [c-
32P]-ATP. The samples were electrophoresed using SDS-PAGE
and transferred to a PVDF membrane. They were then either
autoradiographed or immunoblotted. Phospho-PUM2 radioactiv-
ity could be detected in the in vitro kinase reaction contain 0.5 mgo f
substrate (PUM2) and only in the presence of Aurora-A.
(TIF)
Figure S3 PUM2D434–740, lacking the S motif and the
sequence preceding the PUM-HD motif, were not able to
bind to Aurora-A. HEK293T cells were transfected with HA-
tagged Aurora-A in combination with wild-type FLAG-tagged
PUM2 or FLAG-tagged PUM2 deleted mutant, PUM2D434–740.
The cell lysates were immunoprecipitated with an anti-HA
antibody and then immunoblotted with an anti-FLAG antibody
to detect PUM2.
(TIF)
Figure S4 The stability of Aurora-A is regulated by
Cdh1 but not Cdc20. HEK293T cells were transfected with
FLAG-tagged Aurora-A, either alone or with different amounts of
FLAG-taggedCdh1 (A) or Cdc20 (B). An empty vector was added
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